Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
KNSA
Showing 0 of 12 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in Kiniksa Pharmaceuticals International, plc
No. Jacobs Levy Equity Management exited its KNSA (Kiniksa Pharmaceuticals International) position in Q2 2023. Its Q1 2023 13F listed 293,500 shares worth $3.2M. Jacobs Levy Equity Management first reported KNSA in Q4 2019 and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.